Detalles de la búsqueda
1.
Enhancement of HIV-1 Env-Specific CD8 T Cell Responses Using Interferon-Stimulated Gene 15 as an Immune Adjuvant.
J Virol;
95(2)2020 12 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33115866
2.
Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCV.
J Virol;
93(7)2019 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30674625
3.
Tauopathy Analysis in P301S Mouse Model of Alzheimer Disease Immunized With DNA and MVA Poxvirus-Based Vaccines Expressing Human Full-Length 4R2N or 3RC Tau Proteins.
Vaccines (Basel);
8(1)2020 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-32183198
4.
Deletion of Vaccinia Virus A40R Gene Improves the Immunogenicity of the HIV-1 Vaccine Candidate MVA-B.
Vaccines (Basel);
8(1)2020 Feb 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32041218
5.
Optimized Hepatitis C Virus (HCV) E2 Glycoproteins and their Immunogenicity in Combination with MVA-HCV.
Vaccines (Basel);
8(3)2020 Aug 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32764419
6.
An MVA Vector Expressing HIV-1 Envelope under the Control of a Potent Vaccinia Virus Promoter as a Promising Strategy in HIV/AIDS Vaccine Design.
Vaccines (Basel);
7(4)2019 Dec 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31817622
7.
Removal of the C6 Vaccinia Virus Interferon-ß Inhibitor in the Hepatitis C Vaccine Candidate MVA-HCV Elicited in Mice High Immunogenicity in Spite of Reduced Host Gene Expression.
Viruses;
10(8)2018 08 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30096846
Resultados
1 -
7
de 7
1
Próxima >
>>